An OpenAI researcher is leaving to build a $2bn AI drug startup that has no name yet
OpenAI researcher Miles Wang is leaving to launch an AI drug discovery startup, reportedly in talks to raise $200 million at a $2 billion valuation, with Lightspeed as lead investor. The unnamed compa…